Gene transfer to the cerebellum

Cerebellum

Volumn 9, Issue 4, 2010, Pages 587-597

  Louboutin, Jean Pierre ^a   Reyes, Beverly A S ^a   Van Bockstaele, Elisabeth J ^a   Strayer, David S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cerebellum; Gene transfer; SV40

Indexed keywords

CALBINDIN; EPITOPE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEF PROTEIN; RETROVIRUS VECTOR; VIRUS T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL TRANSFER; CELLULAR DISTRIBUTION; CEREBELLUM DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EXPRESSION VECTOR; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RAT; STABLE EXPRESSION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; CELL COUNT; CEREBELLUM; FEMALE; GENE EXPRESSION; GENE PRODUCTS, NEF; GENETIC VECTORS; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SIMIAN VIRUS 40; STATISTICS, NONPARAMETRIC; TRANSDUCTION, GENETIC;

EID: 79952738287     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1007/s12311-010-0202-9     Document Type: Article

References (59)

1. Ito M. Historical review of the significance of the cerebellum and the role of Purkinje cells in motor learning. Ann NY Acad Sci. 2002;978:273-88. (Pubitemid 36127117)
2. Manto M, Marmolino D. Cerebellar ataxias. Curr Opin Neurol. 2009;22:419-29.
3. Koeppen AH. The hereditary ataxias. J Neuropathol Exp Neurol. 1998;57:531-43. (Pubitemid 28265596)
4. Underwood BR, Rubinsztein DC. Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies. Cerebellum. 2008;7:215-21.
5. Strayer DS, Pomerantz RJ, Yu M, Rosenzweig M, Bouhamdan M, Yurasov S, et al. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors. Gene Ther. 2000;7:886-95. (Pubitemid 30303586)
6. Strayer DS. SV40 as an effective gene transfer vector in vivo. J Biol Chem. 1996;271:24741-6. (Pubitemid 26333219)
7. Strayer DS, Kondo R, Milano J, Duan LX. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells. Gene Ther. 1997;4:219-25. (Pubitemid 27182075)
8. Cordelier P, Calarota SA, Pomerantz RJ, Xiaoshan J, Strayer DS. Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector. J Interferon Cytokine Res. 2003;23:477-88. (Pubitemid 37130071)
9. Cordelier P, Van Bockstaele E, Calarota SA, Strayer DS. Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. Mol Ther. 2003;7:801-10. (Pubitemid 36790257)
10. Cordelier P, Strayer DS. Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia. Virus Res. 2006;118:87-97.
11. Louboutin JP, Reyes BAS, Agrawal L, van Bockstaele EJ, Strayer DS. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors. Gene Ther. 2007;14:939-49. (Pubitemid 46865505)
12. Agrawal L, Louboutin JP, Reyes BAS, van Bockstaele EJ, Strayer DS. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis. Gene Ther. 2006;13:1645-56. (Pubitemid 44774209)
13. Agrawal L, Louboutin JP, Strayer DS. Preventing HIV-1 Tatinduced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications. Virology. 2007;363:462-72. (Pubitemid 46764954)
14. Louboutin JP, Agrawal L, Reyes BAS, van Bockstaele EJ, Strayer DS. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors. Gene Ther. 2007;14:1650-61. (Pubitemid 350143190)
15. Louboutin JP, Agrawal L, Reyes BAS, van Bockstaele EJ, Strayer DS. HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzyme. Neurobiol Dis. 2009;34:462-76.
16. Strayer DS. Gene therapy using SV40-derived vectors: what does the future hold? J Cell Physiol. 1999;181:375-84.
17. McKee HJ, Strayer DS. Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector. Vaccine. 2002;20:3613-25. (Pubitemid 35248087)
18. Strayer DS, Lamothe M, Wei D, Milano J, Kondo R. Generation of recombinant SV40 vectors for gene transfer. SV40 protocols. In: Raptis L, editor. Methods in molecular biology, vol. 165. Totowa: Humana; 2001. p. 103-17.
19. Sauter BV, Parashar B, Chowdhury NR, Kadakol A, Ilan Y, Singh H, et al. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in Gunn rats. Gastroenterology. 2000;119:1348-57.
20. Paxinos G.Watson C. In: Paxinos G,Watson C, editors. The rat brain in stereotaxic coordinates. 2nd ed. New York: Academic; 1986.
21. Rouger K, Louboutin JP, Villanova M, Cherel Y, Fardeau M. X-linked vacuolated myopathy: TNF-alpha and IFN-gamma expression in muscle fibers with MHC class I on sarcolemma. Am J Pathol. 2001;158:355-9. (Pubitemid 32158596)
22. Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development. 1992;116:201-11.
23. Wolf HK, Buslei R, Schmidt-Kastner R, Schmidt-Kastner PK, Pietsch T, Wiestler OD, et al. NeuN: a useful marker for diagnostic histopathology. J Histochem Cytochem. 1996;44:1167-71. (Pubitemid 26337294)
24. Bigini P, Gardoni F, Barbera S, Cagnotto A, Fumagalli E, Longhi A, et al. Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice. BMC Neurosci. 2006;7:71.
25. Morinville A, Cahill CM, Aibak H, Rymar VV, Pradhan A, Hoffert C, et al. Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci. 2004;24:5549-59. (Pubitemid 38812637)
26. Nikonov AA, Finger TE, Caprio J. Beyond the olfactory bulb: an odotopic map in the forebrain. Proc Natl Acad Sci U S A. 2005;102:18688-93. (Pubitemid 43011287)
27. Louboutin JP, Liu B, Reyes BAS, Van Bockstaele EJ, Strayer DS. Rat bone marrow transduced in situ by rSV40 vectors differentiate into multiple central nervous cell lineages. Stem Cells. 2006;24:2801-9. (Pubitemid 46053017)
28. Mandel RJ, Rendahl KG, Spratt SK, Snyder RO, Cohen LK, Leff SE. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J Neurosci. 1998;18:4271-84. (Pubitemid 28243820)
29. Betz AL, Shakui P, Davidson BL. Gene transfer to rodent brain with recombinant adenoviral vectors: effects of infusion parameters, infectious titer, and virus concentration on transduction volume. Exp Neurol. 1998;150:136-42. (Pubitemid 28146432)
30. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet. 1993;3:224-8. (Pubitemid 23096557)
31. Wu P, Phillips MI, Bui J, Terwilliger EF. Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J Virol. 1998;72:5919-26. (Pubitemid 28283380)
32. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 1996;713:99-107. (Pubitemid 26114833)
33. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A. 1996;93:11382-8. (Pubitemid 26347130)
34. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263-7.
35. Watson DJ, Kobinger GP, Passini MA, Wilson JM, Wolfe JH. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther. 2002;5:528-37. (Pubitemid 34546082)
36. Latchman DS, Coffin RS. Viral vectors for gene therapy in Parkinson's disease. Rev Neurosci. 2001;12:69-78. (Pubitemid 32182773)
37. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 2000;290:767-73.
38. Bosch A, Perret E, Desmaris N, Trono D, Heard JM. Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum Gene Ther. 2000;11:1139-50. (Pubitemid 30331580)
39. Daly TM, Vogler C, Levy B, Haskins ME, Sands MS. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci U S A. 1999;96:2296-300. (Pubitemid 29117908)
40. Taylor RM, Wolfe JH. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase. Nat Med. 1997;3:771-4. (Pubitemid 27298722)
41. Skorupa AF, Fisher KJ, Wilson JM, Parente MK, Wolfe JH. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol. 1999;160:17-27.
42. Hannas-Djebbara Z, Didier-Bazs M, Sacchettoni S, Prod'hon C, Jouvet M, Belin MF, et al. Transgene expression of plasmid DNAs directed by viral or neural promoters in the rat brain. Brain Res Mol Brain Res. 1997;46:91-9.
43. Hashimoto M, Aruga J, Hosoya Y, Kanegae Y, Saito I, Mikoshiba K. A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum Gene Ther. 1996;7:149-58. (Pubitemid 26044834)
44. Terashima T, Miwa A, Kanegae Y, Saito I, Okado H. Retrograde and anterograde labeling of cerebellar afferent projection by the injection of recombinant adenoviral vectors into the mouse cerebellar cortex. Anat Embryol. 1997;196:363-82. (Pubitemid 27489960)
45. Iino M, Goto K, Kakegawa W, Okado H, Sudo M, Ishiuchi S, et al. Glia-synapse interaction through Ca2+-permeable AMPA receptors in Bergmann glia. Science. 2001;292:926-9. (Pubitemid 32422489)
46. Yang Y, Haecker SE, Su Q, Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet. 1996;5:1703-12. (Pubitemid 26372405)
47. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A. 2000;97:3428-32.
48. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther. 2004;10:302-17.
49. Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT, et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med. 2004;10:816-20. (Pubitemid 39070854)
50. Alisky JM, Hughes SM, Sauter SL, Jolly D, Dubensky TW, Staber PD, et al. Transduction of murine cerebellar neurons with recombinant FIVand AAV5 vectors. NeuroReport. 2000;11:2669-73.
51. Kaemmerer WF, Reddy RG, Warlick CA, Hartung SD, Mclvor RS, Low WC. In vivo transduction of cerebellar Purkinje cells using adeno-associated virus vectors. Mol Ther. 2000;2:446-57.
52. Belur LR, Kaemmerer WF, McIvor RS, Low WC. Adeno-associated virus type 2 vectors: transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1. Arch Virol. 2008;153:2107-10.
53. Hirai H. Progress in transduction of cerebellar Purkinje cells in vivo using viral vectors. Cerebellum. 2008;7:273-8.
54. Torashima T, Okoyama S, Nishizaki T, Hirai H. In vivo transduction of murine cerebellar Purkinje cells by HIV-derived lentiviral vectors. Brain Res. 2006;1082:11-22.
55. Torashima T, Yamada N, Itoh M, Yamamoto A, Hirai H. Exposure of lentiviral vectors to subneutral pH shifts the tropism from Purkinje cells to Bergman glia. Eur J Neurosci. 2006;24:371-80. (Pubitemid 44100329)
56. Croci C, Fasano S, Superchi D, Perani L, Martellosio A, Brambilla R, et al. Cerebellar neurons and glial cells are transducible by lentiviral vectors without decrease of cerebellar functions. Dev Neurosci. 2006;28:216-21.
57. Agudo M, Trejo JL, Lim F, Avila J, Torres-Aleman I, Diaz-Nido J, et al. Highly efficient and specific gene transfer to Purkinje cells in vivo using a herpes simplex virus 1 amplicon. Hum Gene Ther. 2002;13:665-74. (Pubitemid 34264316)
58. Duan YY, Wu J, Zhu JL, Liu SL, Ozaki I, Strayer DS, et al. Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors. Gastroenterology. 2004;127:1222-32. (Pubitemid 39345890)
59. Strayer DS, Milano J. SV40 mediates stable gene transfer in vivo. Gene Ther. 1996;3:581-7. (Pubitemid 26258272)